Skip to main content
Top
Published in: Surgical Endoscopy 1/2016

01-01-2016

Feasibility, efficacy and safety of stent insertion as a palliative treatment for malignant strictures in the cervical segment of the esophagus and the hypopharynx

Authors: Giorgio Battaglia, Alessandro Antonello, Stefano Realdon, Francesco Cavallin, Francesca Giacomini, Sauid Ishaq

Published in: Surgical Endoscopy | Issue 1/2016

Login to get access

Abstract

Background

50 % of esophageal cancers are inoperable at the time of diagnosis, and around 15 % involve the cervical esophagus. The hypopharynx is often involved by these malignancies as well. Palliation of cervical esophageal malignancies through stent insertion is considered limited due to technical challenges, poor patient tolerance and high complication rate. The aim of this study is to review our experience with stent insertion in the cervical segment of the esophagus and to evaluate outcome differences between stent insertions involving or sparing the hypopharynx.

Methods

We retrospectively reviewed data on 69 consecutive patients that underwent stent insertion for malignant strictures in the cervical esophagus at our Department. Patients were divided according to involvement or sparing of the lower hypopharynx. Dysphagia severity was measured with the Mellow–Pinkas scale before the procedure and on monthly follow-ups. Any complication and its management were recorded. The main outcome parameters were as follows: dysphagia improvement, rate of successful dysphagia palliation (i.e., a reduction of the score to 0 or 1 after stent insertion) and complication rate. Multivariable analysis was carried out to assess the influence of patient- and procedure-related factors on the outcome of the procedure.

Results

Stent insertion was achieved in 100 % patients. At 4 weeks, dysphagia score improved from a median of 3–0 (p < 0.001), and a successful palliation was achieved in 76.8 % patients. The 30-day mortality rate was 14.5 %. Successful palliation throughout the follow-up was achieved in 72.9 % of the surviving patients. Complications occurred in 31.9 % patients. Dilation before stent insertion was associated with a less efficient short-term dysphagia palliation (OR 6.77, 95 % CI 1.46–31.29, p = 0.02).

Conclusions

Stent insertion is a safe and effective palliative treatment for malignant cervical esophageal strictures. Results are consistent even in patients with hypopharyngeal lesions. Dilation should be avoided before stent insertion.
Literature
1.
go back to reference Hill JL, Norberg HP, Smith MD, Young JA, Reyes HM (1976) Clinical technique and success of the esophageal stent to prevent corrosive strictures. J Pediatr Surg 11:443–450PubMedCrossRef Hill JL, Norberg HP, Smith MD, Young JA, Reyes HM (1976) Clinical technique and success of the esophageal stent to prevent corrosive strictures. J Pediatr Surg 11:443–450PubMedCrossRef
2.
go back to reference Costamagna G, Marchese M, Iacopini F (2006) Self-expanding stents in oesophageal cancer. Eur J Gastroenterol Hepatol 18(11):1177–1180PubMedCrossRef Costamagna G, Marchese M, Iacopini F (2006) Self-expanding stents in oesophageal cancer. Eur J Gastroenterol Hepatol 18(11):1177–1180PubMedCrossRef
3.
go back to reference Diamantis G, Scarpa M, Bocus P, Realdon S, Castoro C, Ancona E, Battaglia G (2011) Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. World J Gastroenterol 17:144–150PubMedPubMedCentralCrossRef Diamantis G, Scarpa M, Bocus P, Realdon S, Castoro C, Ancona E, Battaglia G (2011) Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. World J Gastroenterol 17:144–150PubMedPubMedCentralCrossRef
4.
go back to reference Sharma P, Kozarek R, Practice Parameters Committee of American College of Gastroenterology (2010) Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 105:258–273PubMedCrossRef Sharma P, Kozarek R, Practice Parameters Committee of American College of Gastroenterology (2010) Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 105:258–273PubMedCrossRef
5.
go back to reference Raymondi R, Pereira-Lima JC, Valves A, Morales GF, Marques D, Lopes CV, Marroni CA (2008) Endoscopic dilation of benign esophageal strictures without fluoroscopy: experience of 2750 procedures. Hepatogastroenterology 55(85):1342–1348PubMed Raymondi R, Pereira-Lima JC, Valves A, Morales GF, Marques D, Lopes CV, Marroni CA (2008) Endoscopic dilation of benign esophageal strictures without fluoroscopy: experience of 2750 procedures. Hepatogastroenterology 55(85):1342–1348PubMed
6.
go back to reference Swinnen J, Eisendrath P, Rigaux J, Kahegeshe L, Lemmers A, Le Moine O, Deviére J (2011) Self-expandable metal stents for the treatment of benign upper GI leaks and perforations. Gastrointest Endosc 73(5):890–899PubMedCrossRef Swinnen J, Eisendrath P, Rigaux J, Kahegeshe L, Lemmers A, Le Moine O, Deviére J (2011) Self-expandable metal stents for the treatment of benign upper GI leaks and perforations. Gastrointest Endosc 73(5):890–899PubMedCrossRef
7.
go back to reference Baron TH (2001) Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681–1687PubMedCrossRef Baron TH (2001) Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681–1687PubMedCrossRef
8.
go back to reference Conigliaro R, Battaglia G, Repici A, De Pretis G, Ghezzo L, Bittinger M, Messmann H, Demarquay JF, Togni M, Blanchi S, Filiberti R, Conio M (2007) Polyflex stents for malignant oesophageal and oesophagogastric strictures: a prospective, multicentric study. Eur J Gastroenterol Hepatol 19:195–203PubMedCrossRef Conigliaro R, Battaglia G, Repici A, De Pretis G, Ghezzo L, Bittinger M, Messmann H, Demarquay JF, Togni M, Blanchi S, Filiberti R, Conio M (2007) Polyflex stents for malignant oesophageal and oesophagogastric strictures: a prospective, multicentric study. Eur J Gastroenterol Hepatol 19:195–203PubMedCrossRef
9.
go back to reference Johnson E, Enden T, Noreng HJ (2006) Survival and adverse events after insertion of self-expandable metal stents for malignant oesophageal stenosis. Scand J Gastroenterol 41:252–256PubMedCrossRef Johnson E, Enden T, Noreng HJ (2006) Survival and adverse events after insertion of self-expandable metal stents for malignant oesophageal stenosis. Scand J Gastroenterol 41:252–256PubMedCrossRef
11.
go back to reference Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD (2001) Delayed adverse events after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 12:465–474PubMedCrossRef Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD (2001) Delayed adverse events after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 12:465–474PubMedCrossRef
12.
go back to reference Homann N, Noftz MR, Klingenberg-Noftz RD, Ludwig D (2008) Delayed adverse events after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci 53:334–340PubMedCrossRef Homann N, Noftz MR, Klingenberg-Noftz RD, Ludwig D (2008) Delayed adverse events after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci 53:334–340PubMedCrossRef
13.
go back to reference Ramirez FC, Dennert B, Zierer ST, Sanowski RA (1997) Esophageal self-expandable metallic stents—indications, practice, techniques, and adverse events: results of a national survey. Gastrointest Endosc 45:360–364PubMedCrossRef Ramirez FC, Dennert B, Zierer ST, Sanowski RA (1997) Esophageal self-expandable metallic stents—indications, practice, techniques, and adverse events: results of a national survey. Gastrointest Endosc 45:360–364PubMedCrossRef
14.
go back to reference Triboulet JB, Mariette C, Chevalier D, Amrouni H (2001) Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg 136(10):1164–1170PubMedCrossRef Triboulet JB, Mariette C, Chevalier D, Amrouni H (2001) Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg 136(10):1164–1170PubMedCrossRef
15.
go back to reference Laterza E, Mosciaro O, Urso US, Inaspettato C, Cordiano G (1994) Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepatogastroenterology 41(3):278–282PubMed Laterza E, Mosciaro O, Urso US, Inaspettato C, Cordiano G (1994) Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepatogastroenterology 41(3):278–282PubMed
16.
go back to reference Loizou LA, Rampton D, Bown SG (1992) Treatment of malignant strictures of the cervical segment of the esophagus by endoscopic intubation using modified endoprosthesis. Gastrointest Endosc 38:158–164PubMedCrossRef Loizou LA, Rampton D, Bown SG (1992) Treatment of malignant strictures of the cervical segment of the esophagus by endoscopic intubation using modified endoprosthesis. Gastrointest Endosc 38:158–164PubMedCrossRef
17.
go back to reference Goldshmid S, Boyce HW Jr, Nord HJ, Brady PG (1988) Treatment of pharyngoesophageal stenosis by polyvinyl prosthesis. Am J Gastroenterol 83:513–518 Goldshmid S, Boyce HW Jr, Nord HJ, Brady PG (1988) Treatment of pharyngoesophageal stenosis by polyvinyl prosthesis. Am J Gastroenterol 83:513–518
18.
go back to reference Gislason GT, Pasricha PJ (1997) Crossing the upper limit: esophageal stenting in the proximal esophagus. Dysphagia 12:84–85PubMed Gislason GT, Pasricha PJ (1997) Crossing the upper limit: esophageal stenting in the proximal esophagus. Dysphagia 12:84–85PubMed
19.
go back to reference Elefteriadis E, Kotzampassi K (2006) Endoprosthesis implantation at the pharyngo-esophageal level: problems, limitations and challenges. World J Gastroenterol 12(13):2103–2108 Elefteriadis E, Kotzampassi K (2006) Endoprosthesis implantation at the pharyngo-esophageal level: problems, limitations and challenges. World J Gastroenterol 12(13):2103–2108
20.
go back to reference Bayratkar O, Bayratkar B, Atasoy D, Erenler I, Ozdemir IA, Boluk S, Bayraktar OU, Bayraktar A, Tortum OB, Yigitbasi R (2013) Covered self expandable metallic stents could be successful in the palliation of malignant esophageal strictures: preliminary report. Surg Laparosc Endosc Percutan Tech 23(2):e41–e44. doi:10.1097/SLE.0b013e318275b35f CrossRef Bayratkar O, Bayratkar B, Atasoy D, Erenler I, Ozdemir IA, Boluk S, Bayraktar OU, Bayraktar A, Tortum OB, Yigitbasi R (2013) Covered self expandable metallic stents could be successful in the palliation of malignant esophageal strictures: preliminary report. Surg Laparosc Endosc Percutan Tech 23(2):e41–e44. doi:10.​1097/​SLE.​0b013e318275b35f​ CrossRef
21.
go back to reference Choi EK, Song HY, Kim JW, Shin JH, Kim KR, Kim JH, Kim SB, Jung HY, Park SI (2007) Covered metallic stent placement in the management of cervical esophageal strictures. J Vasc Interv Radiol 18(7):888–895PubMedCrossRef Choi EK, Song HY, Kim JW, Shin JH, Kim KR, Kim JH, Kim SB, Jung HY, Park SI (2007) Covered metallic stent placement in the management of cervical esophageal strictures. J Vasc Interv Radiol 18(7):888–895PubMedCrossRef
22.
go back to reference Gallo A, Pagliuca G, de Vincentiis M, Martellucci S, Iallonardi E, Fanello G, Cereatti F, Fiocca F (2012) Endoscopic treatment of benign and malignant strictures of the cervical esophagus and hypopharynx. Ann Otol Rhinol Laryngol 121(2):104–109PubMedCrossRef Gallo A, Pagliuca G, de Vincentiis M, Martellucci S, Iallonardi E, Fanello G, Cereatti F, Fiocca F (2012) Endoscopic treatment of benign and malignant strictures of the cervical esophagus and hypopharynx. Ann Otol Rhinol Laryngol 121(2):104–109PubMedCrossRef
23.
go back to reference Conio M, Caroli-Bosc F, Demarquay JF, Sorbi D, Maes B, Delmont J, Dumas R (1999) Self-expanding metal stents in the palliation of neoplasms of the cervical esophagus. Hepatogastroenterology 46:272–277PubMed Conio M, Caroli-Bosc F, Demarquay JF, Sorbi D, Maes B, Delmont J, Dumas R (1999) Self-expanding metal stents in the palliation of neoplasms of the cervical esophagus. Hepatogastroenterology 46:272–277PubMed
24.
go back to reference Knyrim K, Wagner HJ, Bethge N (1993) A controlled trial of expansible metal stent for palliation of esophageal cancer due to inoperable cancer. N Engl J Med 329:1307CrossRef Knyrim K, Wagner HJ, Bethge N (1993) A controlled trial of expansible metal stent for palliation of esophageal cancer due to inoperable cancer. N Engl J Med 329:1307CrossRef
25.
go back to reference Spinelli P, Cerrai FG, Meroni E (1991) Pharyngo-esophageal prostheses in malignancies of the cervical esophagus. Endoscopy 23:213–214PubMedCrossRef Spinelli P, Cerrai FG, Meroni E (1991) Pharyngo-esophageal prostheses in malignancies of the cervical esophagus. Endoscopy 23:213–214PubMedCrossRef
26.
go back to reference Profili S, Meloni GB, Feo CF, Pischedda A, Bozzo C, Ginesu GC, Canalis GC (2002) Self-expandable metal stents in the management of cervical oesophageal and/or hypopharyngeal strictures. Clin Radiol 57:1028–1103PubMedCrossRef Profili S, Meloni GB, Feo CF, Pischedda A, Bozzo C, Ginesu GC, Canalis GC (2002) Self-expandable metal stents in the management of cervical oesophageal and/or hypopharyngeal strictures. Clin Radiol 57:1028–1103PubMedCrossRef
27.
go back to reference Sarper A, Oz N, Cihangir C, Demircan A, Isin E (2003) The efficacy of self-expanding metal stents for palliation of malignant esophageal strictures and fistulas. Eur J Cardiothorac Surg 23:794–798PubMedCrossRef Sarper A, Oz N, Cihangir C, Demircan A, Isin E (2003) The efficacy of self-expanding metal stents for palliation of malignant esophageal strictures and fistulas. Eur J Cardiothorac Surg 23:794–798PubMedCrossRef
28.
go back to reference Morgan RA, Ellul JP, Denton ER, Glynos M, Mason RC, Adam A (1997) Malignant esophageal fistulas and perforations: management with plastic covered metallic endoprosthesis. Radiology 204:527–532PubMedCrossRef Morgan RA, Ellul JP, Denton ER, Glynos M, Mason RC, Adam A (1997) Malignant esophageal fistulas and perforations: management with plastic covered metallic endoprosthesis. Radiology 204:527–532PubMedCrossRef
29.
go back to reference Shin JH, Song HY, Ko GY, Lim JO, Yoon HK, Sung KB (2004) Esophagorespiratory fistula: long-term results of palliative treatment with covered expandable metallic stents in 61 patients. Radiology 232:252–259PubMedCrossRef Shin JH, Song HY, Ko GY, Lim JO, Yoon HK, Sung KB (2004) Esophagorespiratory fistula: long-term results of palliative treatment with covered expandable metallic stents in 61 patients. Radiology 232:252–259PubMedCrossRef
30.
go back to reference Paganin F, Schouler L, Cuissard L, Noel JB, Becquart J, Besnard M, Bourdin A (2008) Airway and esophageal stenting in patients with advanced esophageal cancer and pulmonary involvement. PLoS One 3(8):e3101PubMedPubMedCentralCrossRef Paganin F, Schouler L, Cuissard L, Noel JB, Becquart J, Besnard M, Bourdin A (2008) Airway and esophageal stenting in patients with advanced esophageal cancer and pulmonary involvement. PLoS One 3(8):e3101PubMedPubMedCentralCrossRef
31.
go back to reference Bethge N, Sommer A, Vakil N (1997) A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest Endosc 45:300–303PubMedCrossRef Bethge N, Sommer A, Vakil N (1997) A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest Endosc 45:300–303PubMedCrossRef
32.
go back to reference Verschuur EM, Kuipers EJ, Siersema PD (2007) Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 66(6):1082–1090PubMedCrossRef Verschuur EM, Kuipers EJ, Siersema PD (2007) Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 66(6):1082–1090PubMedCrossRef
33.
go back to reference Madhusudhan C, Saluja SS, Pal S, Ahuja V, Saran P, Dash NR, Sahni P, Chattopadhyay TK (2009) Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus 22(4):331–336PubMedCrossRef Madhusudhan C, Saluja SS, Pal S, Ahuja V, Saran P, Dash NR, Sahni P, Chattopadhyay TK (2009) Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus 22(4):331–336PubMedCrossRef
34.
go back to reference Bergquist H, Johnsson E, Nyman J, Rylander H, Hammerlid E, Friesland S, Ejnell H, Lundell L, Ruth M (2012) Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer—results of a prospective safety study. Dis Esophagus 25:410–415PubMedCrossRef Bergquist H, Johnsson E, Nyman J, Rylander H, Hammerlid E, Friesland S, Ejnell H, Lundell L, Ruth M (2012) Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer—results of a prospective safety study. Dis Esophagus 25:410–415PubMedCrossRef
35.
go back to reference Yu Y, Tang G, Liu Y, Zhen BZ (2004) Clinical evaluation of radiotherapy for advanced esophageal cancer after metallic stent placement. World J Gastroenterol 10:2145–2146PubMedPubMedCentralCrossRef Yu Y, Tang G, Liu Y, Zhen BZ (2004) Clinical evaluation of radiotherapy for advanced esophageal cancer after metallic stent placement. World J Gastroenterol 10:2145–2146PubMedPubMedCentralCrossRef
36.
go back to reference Maier A, Pinter H, Friehs GB, Renner H, Smolle-Jüttner FM (1999) Self-expandable coated stent after intraluminal treatment for esophageal cancer: a risky procedure? Ann Thorac Surg 67:781–784PubMedCrossRef Maier A, Pinter H, Friehs GB, Renner H, Smolle-Jüttner FM (1999) Self-expandable coated stent after intraluminal treatment for esophageal cancer: a risky procedure? Ann Thorac Surg 67:781–784PubMedCrossRef
37.
go back to reference Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD (2012) Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer. Gastrointest Endosc 76(2):267–274PubMedCrossRef Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD (2012) Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer. Gastrointest Endosc 76(2):267–274PubMedCrossRef
Metadata
Title
Feasibility, efficacy and safety of stent insertion as a palliative treatment for malignant strictures in the cervical segment of the esophagus and the hypopharynx
Authors
Giorgio Battaglia
Alessandro Antonello
Stefano Realdon
Francesco Cavallin
Francesca Giacomini
Sauid Ishaq
Publication date
01-01-2016
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 1/2016
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-015-4176-z

Other articles of this Issue 1/2016

Surgical Endoscopy 1/2016 Go to the issue